Page last updated: 2024-09-03

imidazolium-bis(imidazole)tetrachlororuthenate(iii) and Metastase

imidazolium-bis(imidazole)tetrachlororuthenate(iii) has been researched along with Metastase in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessio, E; Cocchietto, M; Frausin, F; Furlani, A; Sava, G; Scarcia, V; Serli, B1

Other Studies

1 other study(ies) available for imidazolium-bis(imidazole)tetrachlororuthenate(iii) and Metastase

ArticleYear
Free exchange across cells, and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A (imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate) on KB tumor cells.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:1

    Topics: Antineoplastic Agents; Cell Adhesion; Cell Membrane; Fibronectins; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; KB Cells; Kidney; Ligands; Neoplasm Metastasis; Organometallic Compounds; Peptides; Platelet Aggregation Inhibitors; Rhodamines; Spectrophotometry, Atomic

2005